FDA Twitter Ad Study Draws Drug Industry Comment

By Sam | January 31, 2017

Leading drug firms and PhRMA have weighed in on the FDA’s plan to study the risks and benefits of online prescription drug communications and the possible impact of space limitations such as Twitter’s 140-character limit.
Source: Drug Industry Daily

Posted in Drug Industry Daily